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Successful systemic infection of a plant by Tobacco mosaic virus (TMV) requires three
processes that repeat over time: initial establishment and accumulation in invaded cells,
intercellular movement, and systemic transport. Accumulation and intercellular movement
of TMV necessarily involves intracellular transport by complexes containing virus and
host proteins and virus RNA during a dynamic process that can be visualized. Multiple
membranes appear to assist TMV accumulation, while membranes, microﬁlaments and
microtubules appear to assist TMV movement. Here we review cell biological studies
that describe TMV-membrane, -cytoskeleton, and -other host protein interactions which
inﬂuence virus accumulation and movement in leaves and callus tissue. The importance
of understanding the developmental phase of the infection in relationship to the observed
virus-membrane or -host protein interaction is emphasized. Utilizing the latest observations
of TMV-membrane and -host protein interactions within our evolving understanding of the
infection ontogeny, amodel forTMV accumulation and intracellular spread in a cell biological
context is provided.
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INTRODUCTION
Viruses, as obligate organisms, utilize host factors to accumu-
late and spread in their host. A successful infection by a plant
virus includes entry and accumulation in the ﬁrst cell, move-
ment into neighboring uninfected cells, and systemic infection
through the plant vascular tissue (Boevink and Oparka, 2005;
Epel, 2009; Harries and Ding, 2011; Niehl and Heinlein, 2011;
Schoelz et al., 2011; Tilsner et al., 2011). Plant viruses have vary-
ing strategies for infecting hosts which reﬂect their use of existing
functionally redundant host developmental pathways. Therefore
an understanding of virus infection processes also offers insight
into normal host physiological processes. Tobacco mosaic virus
(TMV) encodes four known functional proteins: the 126 and
183 kDa replication-associated proteins, the movement protein
(MP), and the structural capsid or coat protein (CP). In order
to have a successful infection, these four multifunctional pro-
teins cooperate with many host components. The host membrane
and cytoskeleton are sub-cellular structures important for TMV
infection. TMV-induced granules or inclusion bodies that contain
membranes also contain host proteins. In this review, we discuss
the changing roles of host membranes, cytoskeleton, and inclu-
sion body-associated proteins as infection progresses. Findings
reported in the literature are ﬁrst presented in the section(s) where
the effect on virus physiology was observed rather than where it
may additionally inﬂuence this activity. For example, the inﬂu-
ence of synaptotagmin onTMVphysiology (Lewis andLazarowitz,
2010) was reported as an inhibition of intercellular spread of the
TMV MP, although it likely inﬂuences the intracellular transport
of this protein. This was done to clearly indicate what is in the pub-
lished literature rather than what a reader may interpret the results
to indicate. In some instances, however, the presumed inﬂuence
of the observed outcome on the mechanism of virus movement is
noted. As pertinent, ﬁndings from other tobamoviruses are men-
tioned to indicate the generality or speciﬁcity of a conclusion for
the genus.
INITIAL INFECTION
Tobacco mosaic virus enters plant cells only through mechani-
cal wounds which either transiently open the plasma membrane
or allow pinocytosis (Palukaitis and Zaitlin, 1986; Shaw, 1999;
Figure 1). TMV begins to disassemble within 3 min after entry
and disassembly of CP from the capsid is associated with transla-
tion of viral RNA (vRNA;Wu et al., 1994; reviewed in Shaw, 1999).
TMV vRNA labeled with cyanine 3-UTP forms small granules in
cytoplasm less than 5 min after entering the cell (Christensen et al.,
2009). The vRNA-containing granules form where CP and vRNA
co-localize as well as in the absence of CP, suggesting that although
CP was not needed for granule formation the disassembly of TMV
capsids occurred at the site of granule formation. Removal or
mutation of cis and trans elements necessary for virus replication
(i.e., the vRNA 3′ untranslated region and replicase) did not pre-
vent granule formation, although theywere smaller and less stable.
The granules were shown to associate with ﬂuorescently labeled
ER. The 5′ methylguanosine cap on the vRNA was necessary to
anchor vRNA to the ER/actin complex: absence of the cap leading
to vRNA degradation and no granules (Christensen et al., 2009).
Considering that uncoating of vRNA may make it accessible to
the silencing surveillance system (reviewed in Niehl and Heinlein,
2011), it will be important to determine to which host factors
viral proteins are attached during granule formation and trans-
port to cortical and perinuclear replication sites. Identifying host
factors in the granules will be difﬁcult due to their presumed low
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FIGURE 1 | Schematic of a proposed accumulation and movement
pathway forTMV within cells.To simplify the model we do not address the
possibility that the MP or any other viral protein moves within the cell, with or
without viral RNA, independently of the virus replication complex. Also, we do
not address the possibility that host proteins involved in virus accumulation
and movement trafﬁc independently from the virus complexes to support
these activities. TMV capsid enters through an opening within the cell wall
(CW) and plasma membrane (PM) or through pinocytosis after wounding (a).
TMV RNA is released from the capsid at the site of viral RNA (vRNA) granule
formation (b). The granules are associated with the endoplasmic reticulum
(ER), which may serve as the replication site on transport of the vRNA to
cortical vertices or perinuclear regions of the ER. Transport to these locations
requires microﬁlaments (MF) (c). Other membranes such as the vacuolar (V)
membrane may serve as a scaffold for virus replication, but this requires
further analysis. A virus replication complex (VRC) is formed in the cortical
vertices or perinuclear region of the ER (d). VRCs contain vRNA, movement
protein (MP), replication proteins and host proteins. TOM1, a membrane
protein, interacts with replication proteins and serves as an anchor between
the replication proteins and a host membrane, which may be ER (TOM1?),
vacuole (TOM1) or another membrane (e). For TMV intercellular movement,
VRCs move from sites of replication to plasmodesmata (PD). Elongation
factor 1A (EF-1A) interacts with vRNA, replication proteins, MFs and
microtubules (MTs) and inﬂuencesTMV movement. It is unclear if this
inﬂuence is on sustained movement associated with clearance of virus
components within the cell, or with initial movement: we have placed it with
initial movement and with the MF (f). An interaction between two host
proteins, a class II KNOTTED 1-like protein (NTH201) and a DnaJ-like protein
(MPIP1), and theTMV MP also may aid transport of virus to the PD (g),
although again it is unclear if this interaction aids initial or sustained
movement. Movement of the VRC to the PD requires membrane, and may be
inﬂuenced by actomyosin (MF and myosin) and MT (h). The inﬂuence of the
MT end-binding protein (EB1a) on virus movement is placed during transport
to the PD (h). MP microﬁlament severing activity at the PD is proposed to
eliminate F-actin-like structures at the PD to increase the PD size exclusion
limit SEL (i). In addition, interaction between the MP and the ankyrin repeat
containing protein (ANK) is correlated with an increase of the PD SEL through
a decrease in callose at the PD neck (j). vRNA transports through PD within a
VRC or simply with vRNA and MP, the latter being phosphorylated (MPP) in
the PD to release the vRNA for translation in the next cell (k; Karpova et al.,
1997; Lee et al., 2005). After vRNA transfer to the neighboring cell, VRC
remnants associate with endosomes (E; possibly pre-vacuolar vesicles) for
transport to vacuoles, potentially through interaction of the vesicle fusing
protein, synaptotagmin, with the MP (l). Transport is proposed to involve the
actomyosin network. Likely prior to this transport, CELL-DIVISION CYCLE
protein48 (CDC48) extracts the MP from the ER-associated VRC for
attachment to the MT and later degradation (m). N, nucleus.
quantities, but will be necessary to understand the steps prior to
virus replication.
REPLICATION
Tobacco mosaic virus and the very closely related Tomato
mosaic virus (ToMV) use their parental genomes to synthesize
complementary negative strands which serve as templates for
the synthesis of progeny full-length positive strands and subge-
nomicmRNAs containingMPandCPopen reading frames (ORFs;
Ishikawa and Okada, 2004; Ishibashi et al., 2010). Although the
183 kDa protein encoded by the 5′ ORF of these viruses can repli-
cate the genome, the 126 kDa protein, produced by termination
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of translation at an amber stop codon within the 183 kDa pro-
tein ORF, is necessary for maximum progeny RNA production
(Ishikawa et al., 1986; Ishikawa et al., 1991; Lewandowski and
Dawson, 2000). The 126 and 183 kDa proteins contain methyl-
transferase and helicase domains, while the 183 kDa protein alone
contains the C-terminal domain encoding an RNA-dependent
RNA polymerase. The 126 and 183 kDa proteins together will be
referred to as the replication proteins in this review. TMV/ToMV
replication is believed to occur in a membrane-associated com-
plex containing the replication proteins, MP, vRNA, and host
proteins (Hagiwara et al., 2003; Heinlein et al., 1998; Más and
Beachy, 1999; reviewed in Ishibashi et al., 2010; Laliberté and
Sanfaçon, 2010; de Castro et al., 2012; Figure 1). The ER was
implicated as a site for virus replication complex (VRC) formation
through co-localization of an ER marker, BiP, with MP-GFP and
in turn, MP-GFP co-localization with replication proteins during
immunoﬂuorescence studies (Heinlein et al., 1998). Reichel and
Beachy (1998), using transgenic plants expressing an ER-targeted
GFP, determined that the ER formed large cortical aggregates
at reticulate vertices and fewer membrane tubules during TMV
accumulation, but returned to a normal structure after repli-
cation ended. However, later studies with ToMV using both
ﬂuorescence microscopy and biochemical fractionation methods
determined that the replication proteins and replicase activitywere
associated predominantly with the vacuolar membrane, although
they also showed some localization and activity with other less
deﬁned membrane fractions which included the ER (Hagiwara
et al., 2003). Interestingly, ToMV can replicate in cells that are
vacuole-diminished (Nishikiori et al., 2006). This ﬁnding supports
the notion that although the tonoplast may function to support
ToMV/TMV accumulation, other membranes such as the ER are
important for this activity. Clearly, additional work is necessary
to determine which membranes are essential for tobamovirus
accumulation (Figure 1).
Regardless of the membrane used for tobamovirus accumula-
tion, it is clear that a characteristic VRC is not uniformly induced
by tobamoviruses. TMV, ToMV, and Tobacco mild green mosaic
virus (TMGMV), form different subcellular structures contain-
ing replication proteins late in the infection cycle: TMV forming
X-bodies and ToMV and TMGMV forming virus bundles when
analyzed through immunocytochemical EM studies (Das and
Hari, 1992). For a fourth tobamovirus, Turnip vein clearing virus
(TVCV), X-bodies are rare (Resconich, 1961). Early ﬂuorescence
localization studies determined that for strains of TMV the size
of the VRCs varied and was positively correlated with the level
of disease observed (Liu et al., 2005, 2006). Recently, however, it
was determined that silencing expression of the gamma subunit
of ATP synthase, a nuclear-encoded chloroplast protein, resulted
in smaller but more numerousVRCs and severe disease symptoms
(Bhat et al., 2012). Thus, the size of the VRC is not a perfect indi-
cator of disease intensity and the number of VRCs may inﬂuence
this phenotype.
The form of inclusions induced by tobamoviruses is correlated
with differences in the replication protein sequences (Liu et al.,
2005; Harries et al., 2009). While ectopically expressed 126 kDa
protein from TMV fused with GFP forms intracellular inclu-
sions, the 125 kDa protein homolog from TVCV does not form
inclusions (Harries et al., 2009). Interestingly, the intracellular
inclusions formed by the TMV 126 kDa protein co-localized with
microﬁlaments, as observed for the TMV VRC (Liu et al., 2005).
Domain(s) within the 126 kDa protein necessary for inclusion
body formation are not identiﬁed, however, it is known that the
helicase domain when expressed alone is able to form octomers in
vitro (Goregaoker and Culver, 2003) and thus may be a domain
important for this activity. In addition, a 126 kDa protein-GFP
construct expressing only the N terminal 781 amino acids of the
126 kDaprotein associatedwith theERand formed inclusions (dos
Reis Figueira et al., 2002). The 781 amino acid protein includes the
methyltransferase and non-conserved bridge domain that previ-
ously was determined to inﬂuence the RNA silencing suppression
function of this protein. There is unpublished data indicating that
the methyltransferase domain alone can form inclusions (Knapp
et al., 2007). More work is needed to further identify the domains
responsible for inclusion formation and the relevance of inclusion
formation to tobamovirus physiology.
Ectopically expressed TMV MP fused with ﬂuorescent reporter
proteins also can form cytoplasmic inclusion bodies (Heinlein
et al., 1998; Reichel and Beachy, 1998; Sambade et al., 2008).
These small inclusions are similar to those visualized in the cor-
tical periphery during infection with tobamoviruses expressing
an MP-GFP fusion (Padgett et al., 1996; Heinlein et al., 1998;
Reichel and Beachy, 1998; Boyko et al., 2007). The cortical MP-
GFP inclusions that appear during virus infection likely represent
the inclusions containing replication proteins and MP observed by
Szécsi et al. (1999), but this requires conﬁrmation. Inclusions con-
taining MP-GFP associate with microtubules both early and late in
the infection cycle (Heinlein et al., 1998; Boyko et al., 2007; Sam-
bade et al., 2008). Studies with cellular markers and an MP-mRFP
construct containing a downstream non-viral stemloop-forming
RNA aptamer that can be ﬂuorescently labeled determined that
MP-mRFP associates with ER and its own RNA (Sambade et al.,
2008). In this regard, it will be important to determine if multiple
types of inclusions are formed independently during infection or
are always part of a continuum,with progeny inclusions appearing
from parental inclusions.
The host proteins within VRCs or inclusions that contain
them are not fully identiﬁed. Late in infection, TMV-induced X-
bodies have been shown to contain the microtubule component,
β-tubulin, through immunocytochemical EM studies (X. S. Ding
and R. S. Nelson, personal communication). The function of this
protein in X-bodies is unknown, but perhaps it could be to aid
the degradation of body components analogous to the suggested
function of microtubules during TMVMP turnover (Kragler et al.,
2003). The host translation factor, elongation factor 1A (EF-1A),
is present in the membrane-associated fraction where viral repli-
case activitywas observed (OsmanandBuck,1996;Watanabe et al.,
1999) and inX-bodies produced byTMV(Ding et al., 1998). It also
interacts with the 3′-UTR of genomic vRNA and with the methyl-
transferase domain of the replication proteins (Zeenko et al., 2002;
Yamaji et al., 2006). EF-1A has additional activities beyond sup-
porting translation including forming complexes with tubulin
and actin, the actin interaction possibly linking the cytoskeleton
to protein synthesis, and ubiquitin-mediated degradation (Durso
and Cyr, 1994; Gonen et al., 1994; Kim and Coulombe, 2010).
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The function of EF-1A during TMV accumulation was hypothe-
sized to aid minus strand synthesis (Yamaji et al., 2006). However,
down-regulation of EF-1A through virus-induced gene silencing
resulted in the reduced size of green ﬂuorescent lesions induced
by TMV-expressing GFP, but no reduction in lesion numbers or
translation activity in the silenced leaves (Yamaji et al., 2010). This
result suggests that the function of EF-1A is not for translation
or virus accumulation, but for virus movement that may, in some
manner, be linked to the cytoskeleton (Figure 1).
Tobamovirus multiplication 1 (TOM1) is a predicted multi-
pass transmembrane protein required for tobamovirus accumu-
lation (Ishikawa et al., 1993; Yamanaka et al., 2000). Surpris-
ingly, over-expression of TOM1 decreases ToMV multiplication
(Hagiwara-Komoda et al., 2008). This observation is associated
with the ﬁnding that accumulation of the ToMV replication pro-
teins in membrane-free (soluble) fractions was lower for plants
over-expressing TOM1 compared with those not over-expressing
this protein (Hagiwara-Komoda et al., 2008). This result indi-
cates that the level of the soluble form or the ratio of soluble
and membrane-bound forms of the replication proteins is criti-
cal for normal virus accumulation. It was hypothesized that the
soluble form is important for RNA silencing suppressor activity
and it was shown that the loss of suppressor activity is correlated
with diminished accumulation of the virus (Kubota et al., 2003;
Hagiwara-Komoda et al., 2008). TOM1 interacts with the helicase
domain of the 130 kDa protein from the related tobamovirus,
Tobacco mosaic virus-Cg (crucifer-infecting virus), in a yeast two-
hybrid screen (Yamanaka et al., 2000). This interaction was shown
to be with the helicase core region based on predictions from the
crystal structure of the helicase domain (Nishikiori et al., 2012).
The replication proteins fromToMVandTOM1 share similar sub-
cellular fractionation pattern in extracts from infected BY-2 cells,
residing mostly in the tonoplast-containing fractions, but also in
fractionswithothermembranes, including theER (Hagiwara et al.,
2003). It is hypothesized that TOM1 forms a link between the
host membrane in which it resides and the tobamovirus replica-
tion proteins (Figure 1). This interaction is likely important for
VRC formation, but the co-localizationof TOM1and tobamovirus
replication proteins in live cells has not been reported.
INTRACELLULAR MOVEMENT
For TMV to establish a systemic infection, the virus or its com-
ponents must move within a cell to establish an infection site,
multiply and ﬁnally position for movement to the next cell. The
granules of vRNA that form on initial infection, the VRCs that
form during infection and the 126 kDa protein- and MP/vRNA-
containing inclusions observed during ectopic expression all move
within the cell (e.g., Kawakami et al., 2004; Liu et al., 2005; Sam-
bade et al., 2008; Christensen et al., 2009). These complexes may
change their form and constituents with time.
During initial infection, granules containing vRNA anchor to
cortical ER and move to cortical ER vertices and the perinuclear
ER where virus replication and translation occurs (Reichel and
Beachy, 1998; Christensen et al., 2009; Figure 1). Indeed, vRNA
has been visualized in the perinuclear bodies by bimolecular ﬂu-
orescence complementation using a modiﬁed sequence-speciﬁc
RNA-binding protein, Pumilio1, or by classical in situ RNA
labeling (Tilsner et al., 2008). The vRNA must contain a sequence
that targets the ER membrane directly or through a protein that
targets the ER. Why the vRNA moves to particular cortical ER
vertices or the perinuclear ER for replication is unknown. How-
ever, considering that most of the ribosome-containing, or rough,
ER is present in the perinuclear region (Carrasco and Meyer,
2011) it is likely that this location, or a cortical ER vertex also
containing ribosomes, is best suited for virus protein synthesis.
Neither cytochalasin D nor latrunculin B (LatB) treatment, both
microﬁlament antagonists, affect granule formation suggesting
that microﬁlaments are not involved in this initial activity (Chris-
tensen et al., 2009). However, disruption of microﬁlaments results
in granules hovering in the cortical ER, suggesting microﬁlaments
help transport the granules in the cell. In contrast, depolymeriz-
ing microtubules does not stop vRNA granule movement along
the tubular cortical ER (Christensen et al., 2009).
Membranesmay be involved in intracellular trafﬁcking of TMV
components and the virus itself, as a VRC or vRNP, during virus
accumulation and later spread. TMV replication occurs in asso-
ciation with ER and other membranes and both the MP and the
replication proteins associate intrinsically or through a protein
linker with membranes (Brill et al., 2000; Hagiwara et al., 2003;
Fujiki et al., 2006). Interestingly, however, interruption of ER to
Golgi secretory transport, mediated by the host coat complex II
(COP-II) with brefeldin A (BFA) or through over-expression of
a dominant-negative GTPase, Sar1p, did not alter targeting of
ectopically expressed, ﬂuorescently labeled MP to plasmodesmata
(PD; Boutant et al., 2009; Genovés et al., 2010). This result, as well
as BFA studies with infectious virus (see below), indicates that
the COP-II-mediated transport system is not utilized by TMV MP
or TMV to target viral products to the cell periphery. The actual
pathway used by the virus, however, likely includes ER since that
membrane is present in early- and late-formed virus inclusions (by
ﬂuorescence microscopy and EM), with early forming inclusions
paired at the cell wall (e.g., Esau and Cronshaw, 1967; Heinlein
et al., 1998; Szécsi et al., 1999; see below).
Much information is available on the movement of inclusion
bodies containing the viral replication proteins. Several labo-
ratories pursued EM-based immunocytolocalization studies of
TMV infections with antibody against the replication proteins
(Hills et al., 1987; Saito et al., 1987). They noted that the struc-
ture of the inclusions likely changed during development, going
from smoothly granular to containing electron-dense rope-like
structures, composed at least partly of 126 kDa protein, in a
ribosome-rich matrix. Saito et al. (1987) referred to the former
as viroplasms and the latter as X-bodies. Szécsi et al. (1999)
showed through light and EM immunocytolocalization studies
that TMV-induced inclusion bodies with viroplasm and X-body
characteristics changed position and content as infections within
cells developed. Near the infection front the inclusion bodies were
paired on either side of the cell wall and contained both the repli-
cation proteins and MP, while four to six cells back from the front
the bodies were not paired, had moved away from the cell wall
and only contained the replication proteins. Through ﬂuores-
cence microscopy of cells near the infection front, Tilsner et al.
(2008) observed vRNA in small cortical bodies in the peripheral
cytoplasm. They suggested these cortical bodies may represent the
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inclusions at the cell periphery observed by Szécsi et al. (1999).
Motionless small ﬂuorescent bodies in the cell were detected at
12 h post-inoculation and these bodies were moving by 14 h post-
inoculation when tracking TMV expressing an MP-GFP fusion:
a period when both MP and the replication proteins would co-
localize (Kawakami et al., 2004). Movement of the ﬂuorescent
inclusions early in infection, when both replication proteins and
MP would be present, was aligned with microﬁlaments, and
through pharmacological and gene-silencing studies, the inclu-
sions (also referred to as VRCs) were shown to require these intact
microﬁlaments for their intracellular movement (Kawakami et al.,
2004; Liu et al., 2005). The degradation of the microﬁlaments was
not sufﬁcient to decrease virus accumulation to levels that would
prevent virus movement or VRC formation and thus the inﬂu-
ence of microﬁlaments on TMV intracellular movement was not
confounded by a signiﬁcant inhibition of virus replication (Liu
et al., 2005). Treatment with a general myosin motor inhibitor,
2,3-butanedione monoxime (BDM), impaired the intracellular
movement of VRCs (Kawakami et al., 2004).
Boyko et al. (2007), using a chimeric TMV expressing the MP
from the Ob tobamovirus (Padgett et al., 1996), determined that
MP-GFP inclusions at the infection front likely representingVRCs
were associated with and typically trafﬁcked along cortical micro-
tubules for short distances in a stop-and-gomanner (microtubules
labeled with a microtubule-associated protein fused with GFP).
Later studies obtained similar ﬁndings using the native MP of
TMV fusedwithmRFP (Sambade et al., 2008). It was hypothesized
that microtubules serve to anchor and then, through polymer-
ization, release the VRC for movement (Sambade and Heinlein,
2009; reviewed in Peña and Heinlein, 2012). A second hypothe-
sis, to be discussed further in the section on TMV intercellular
movement, was that microtubule polymerization pushes the VRC
along the ER (Peña and Heinlein, 2012). Other research, however,
found that disruption of microtubules through pharmacological
treatment with aminoprophos-methyl, colchicine, or oryzalin, or
by silencing α-tubulin, had no signiﬁcant effect on the transport
of the MP-GFP within cells or to the PD area during infection
(Gillespie et al., 2002; Kawakami et al., 2004; Wright et al., 2007).
Regardingmicroﬁlaments, early studies indicated an associationof
TMV MP with rhodamine-conjugated phalloidin microﬁlaments
after probing cells with polyclonal antibody against the MP and
ﬂuorescein-conjugated secondary antibody (McLean et al., 1995).
Wright et al. (2007) utilized ﬂuorescence recovery after photo-
bleaching (FRAP) to observe MP-GFP movement and found that
microﬁlament antagonists, LatB and cytochalasin B, inhibited MP
targeting to the PD. However, a later study determined that the
MP-GFP expressed during virus infection was not observed to co-
align with ﬂuorescently labeled microﬁlaments (Hofmann et al.,
2009). Lastly, in studying membrane-mediated transport of the
MP, inhibition of ER–Golgi membrane trafﬁcking with BFA at low
concentration (10 μg/ml) did not inhibit MP targeting (Tagami
and Watanabe, 2007; Wright et al., 2007), but did inﬂuence the
structure of the MP-GFP inclusion bodies (Tagami and Watan-
abe, 2007). At high concentration of BFA (100 μg/ml), which
disrupts cortical ER structure, there was a signiﬁcant effect on MP
targeting to the PD (Wright et al., 2007). Thus, during virus infec-
tion the trafﬁcking of the MP within the cell likely requires intact
ER and may require microﬁlaments and microtubules (Figure 1),
although evidence against a direct action for microﬁlaments exists
and microtubules may not be in an intact form or the required
microtubule array is unusual in that it is impervious to certain
pharmacological agents (Seemanpillai et al., 2006).
Although theTMVVRCmoveswithin cells, the replicationpro-
teins and theMP, independent of one another and in the absence of
vRNA, also can transport within the cell. Their independent trans-
port may have physiological relevance. Expression of a fusion of
the TMV 126 kDa protein with GFP yields an intracellular inclu-
sion body that, like the VRC, co-aligns with and trafﬁcs along
microﬁlaments (Liu et al., 2005). As observed for theVRC, disrup-
tion of microﬁlaments ends intracellular transport of the 126 kDa
protein-GFP inclusion body. Furthermore, normal intracellular
movement of the 126 kDa-GFP inclusion body, like TMV sus-
tained intercellular movement, requires myosin XI-2 (see section
on “INTERCELLULAR MOVEMENT” for discussion of myosin
inﬂuence on TMV physiology; Harries et al., 2009; C. Liu, and R.
S. Nelson, personal communication). Whether the 126 kDa pro-
tein directly interacts with microﬁlaments or myosin XI-2 requires
further study. If there is no direct interaction between these pro-
teins, trafﬁcking of virus proteins may be through interaction of
myosin XI-2 with host components associated with a virus-host
protein complex or through the creation of a bulk ﬂow network of
cytoplasmic constituents (i.e., cytoplasmic streaming). Consider-
ing that the viral replication proteinsmay transport independently
of the MP or other viral components to complete their functions,
additional studies of their ectopic transport in relationship to their
transport during virus infection are needed. The difﬁculty in pur-
suing studies on the viral replication proteins is that no fusion
between the replication proteins and a ﬂuorescentmarker has been
developed that yields a viable virus. This needs to be addressed for
further progress to occur.
Transient expression of the MP fused with ﬂuorescent mark-
ers results in the formation of inclusions that associate with RNA
and associate with and trafﬁc along the ER, perhaps interacting
with a microtubule scaffold necessary for movement (Sambade
and Heinlein, 2009). Both microﬁlament and microtubule antag-
onists inhibited intracellular transport of the MP-ﬂuorescent
marker fusion, the results from the latter treatment (using
aminoprophos-methyl) being a different ﬁnding from many dur-
ing virus infection where MP-GFP fusion movement was not
impeded by microtubule antagonists. To complicate this situa-
tion further, additional research determined that neither oryzalin
or aminoprophos-methyl, both antagonists of microtubules, nor
LatB, a microﬁlament antagonist, inhibited the formation of MP-
GFP inclusions or their localization to the cell periphery or PD
in cultured cells or leaves (Prokhnevsky et al., 2005; Boutant et al.,
2009). These apparently conﬂicting results highlight the difﬁculty
interpreting ﬁndings from pharmacological studies. Clearly, addi-
tional work is required to determine, in real time and through
methods using non-pharmacological techniques, the inﬂuence of
the cytoskeleton on transiently expressed MP intracellular traf-
ﬁcking. Assuming MP trafﬁcking independent of the VRC has
physiological relevance, ﬁndings from these additional studies
would provide further insight into the mechanism of TMV intra-
cellular movement. Some work investigating the inﬂuence of MP
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transport in the absence of pharmacological treatment has been
published. For example, Kotlizky et al. (2001) determined that
an ectopically expressed MP mutant-GFP fusion, MPNT−1-GFP,
which inhibits TMV spread when expressed in transgenic plants,
was able to associate with microtubules but did not target PD or
move between cells. This suggests that the microtubule binding
domain resides in a different location from the region important
for PD localization and supports the pharmacological studies indi-
cating that MP PD localization and initial virus spread requires
more than microtubule association by the MP.
INTERCELLULAR MOVEMENT
As for intracellular movement, our understanding of TMV inter-
cellular movement is fragmented. It is certain, however, that TMV
utilizes PD to move between cells. PD are bounded by the plasma
membrane and contain a cytoplasmic sleeve between this mem-
brane and intact ER, the ER referred to as the desmotubule in this
tissue (Lucas et al., 2009; Benitez-Alfonso et al., 2010; White and
Barton, 2011; Figure 1). Callose is present in the neck region of the
PD (Northcote et al., 1989; see Benitez-Alfonso et al., 2010). Actin
and myosin are among multiple protein components in the cyto-
plasmic sleeve (Fernandez-Calvino et al., 2011; White and Barton,
2011). The size exclusion limit (SEL) of PD allows the passive
diffusion of small molecules ∼1 kDa in size. This presents an
impediment to virus movement because virus structures that are
hypothesized to move between cells require a far larger SEL. The
MP of TMV modiﬁes the SEL of the PD to facilitate virus move-
ment through PD and ﬂuorescently labeled MP is observed in PD
after virus spread has occurred (reviewed in Benitez-Alfonso et al.,
2010; Niehl and Heinlein, 2011). The MP itself also can move
between cells when ectopically expressed (reviewed in Niehl and
Heinlein, 2011). The increase in PD SEL during TMV spread is
transient, returning to a restricted size after passage of the infection
front as measured by ﬂuorescence expressed from the TMV-GFP
genome (Oparka et al., 1997). Microﬁlament antagonists lead to a
signiﬁcant increase in the PD SEL while those that stabilize micro-
ﬁlaments prevent theMP from increasing the PD SEL (White et al.,
1994; Ding et al., 1996; Su et al., 2010). The TMV MP exhibits
microﬁlament severing activity (Su et al., 2010). These ﬁndings, in
total, suggest a mechanism for virus spread where TMV MP opens
PD through its microﬁlament severing activity, mimicking the
phenotype induced with microﬁlament antagonists (Figure 1). Su
et al. (2010) hypothesized that the severing activity of theTMVMP
was limited to the PD area by analogy with ﬁndings from a mutant
MP of Cucumber mosaic virus altered in its ability to target the
PD. This mutant MP, which also has severing activity, fragments
microﬁlaments in the cytoplasm (Su et al., 2010). Besides the MP,
evidence for the VRC moving between cells has been published
(Kawakami et al., 2004), but there have been no subsequent reports
supporting this ﬁnding. The 126 kDa protein fused with GFP has
not been reported tomovebetween cells during ectopic expression,
suggesting that VRC intercellular movement requires expres-
sion of additional viral proteins (likely the MP) or the presence
of the vRNA.
In addition to innate actin severing activity by the TMV
MP that may enlarge PD, the TMV MP interacts with ankyrin
repeat-containing protein, ANK, at the PD and this association
is correlated with an increase the PD SEL (Ueki et al., 2010).
ANK has multiple activities, including binding to and deliver-
ing chloroplasts to their destination, supporting disease resistance
against bacteria and virus challenge and participating in reactive
oxygen scavenging, but it does not have callose degrading activ-
ity. Over-expressing ANK in transgenic plants resulted in more
extensive MP-YFP and TMV-DsRed spread between cells. During
transient expression of ANKandMP, the level of callose in the neck
region of the PDdecreased. Previously it was shown that enhanced
TMV intercellular spread was correlated with enhanced expres-
sion of the callose-degrading enzyme, β -1, 3-glucanase (Bucher
et al., 2001). Whether predominantly cytoplasmic ANK, through
its MP interaction and the MP interaction with membrane, targets
β -1, 3-glucanase in ER-derived vesicles to the cell wall or if ANK
functions directly to inhibit callose synthase activity, remains to
be determined (Ueki et al., 2010; Figure 1). Interactions of the
TMVMPwith other host proteins that inﬂuence TMV spread have
been described (e.g., pectin methyl-esterase; Chen et al., 2000).
However, in many instances cell biological studies to observe the
interaction between the MP and host proteins within a live cell
have not been conducted to further determine the location where
the interaction may inﬂuence intercellular spread.
Regarding microtubules and TMV intercellular movement,
there is evidence that MP interaction with the microtubule end-
binding protein 1a (EB1a) is important for TMV spread. Brandner
et al. (2008) determined that EB1a-GFP and MP-GFP form com-
plexes both in vitro and in vivo. EB1a-GFP sub-cellular localization
during TMV infection was altered from end labeling comet-
like structures representing growing microtubules to labeling the
length of microtubules. The length-wise decoration of micro-
tubules was associated with a co-localization of MP-RFP. This
unexpected re-localization of the EB1a protein at the infection
front was correlated with an inhibition of virus intercellular
spread. Ouko et al. (2010) determined that a mutant tobacco
expressing a detyrosinated α-tubulin had a slower moving GFP-
EB1 and inhibited intercellular spread by TMV. These studies
suggest that modiﬁed microtubule dynamics inhibits TMV inter-
cellular spread, perhaps by inhibiting microtubule polymerization
that normally would push the VRC along the ER during intracel-
lular transport (reviewed in Peña and Heinlein, 2012; Figure 1).
These ﬁndings support those using a mutant strain of TMV whose
temperature sensitive intercellular movement is correlated with
the temperature sensitive localization of MP with microtubules
(Boyko et al., 2007). However, other studies using pharmacolog-
ical agents or silencing of the α-tubulin gene found no effect of
these treatments onTMV intercellular spread or on the presence of
MP in PD (Gillespie et al., 2002). Additionally, a virus expressing
a modiﬁed MP with limited afﬁnity for microtubules displayed
enhanced intercellular spread (Gillespie et al., 2002). These and
other ﬁndings from studies of a microtubule-binding protein,
MPB2C, which binds to the MP and when overexpressed has a
negative effect on intercellularmovement of a related tobamovirus
(Ruggenthaler et al., 2009), led to the suggestion that the function
of microtubules in TMV spread is for degradation of the MP.
Recently, it was determined that a CELL-DIVISION CYCLE pro-
tein48 (CDC48) fromArabidopsis, which localizes in the cytoplasm
near the cortical ERnetwork, interactswith theTMVMP to extract
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it from ER for its subsequent accumulation on microtubules
(Niehl et al., 2012). These authors also determined that overex-
pression of CDC48 in infected tissue inhibited virus spread. Thus,
it appears that removal of the MP from the ER at the infection
front and its movement to the microtubules through CDC48
activity is directed toward processing and possibly, degrading,
the MP (Figure 1).
Microﬁlaments have been shown to be important for TMV
intercellular movement, but the interpretation of their involve-
ment in this activity is evolving. Findings from early studies using
a GFP-labeled virus showed that disruption of microﬁlaments,
through pharmacological methods or by silencing actin, inhibited
sustained (2 days and beyond post-inoculation) virus intercel-
lular movement (Kawakami et al., 2004; Liu et al., 2005). This
inhibition in sustained intercellular spread was not associated
with a decrease in virus accumulation per cell that would affect
virus movement or prevent VRC formation (Liu et al., 2005). In
addition, the sustained virus intercellular movement was not cor-
related with VRC size (Liu et al., 2005). This movement required
myosin motor activity and speciﬁcally myosin XI-2 motor activity
(Kawakami et al., 2004; Harries et al., 2009). Surprisingly, intercel-
lular movement of the related tobamovirus, TVCV,was unaffected
by disruption of microﬁlaments or silencing of any myosin stud-
ied to date (Harries et al., 2009). During this time, it also was
shown that TMV was not inhibited in spread early after LatB
treatment (i.e., movement up to 24 h after treatment; Hofmann
et al., 2009). In addition, these researchers determined that actin
binding domain 2 (ABD2)-GFP, expressed in transgenic plants,
inhibited TMV movement. They concluded that this disruption
in virus movement was primarily due to a loss of membrane
ﬂuidity caused by the ABD2-GFP marker and that TMV inter-
cellular movement was predominantly inﬂuenced by membrane
diffusion characteristics. Thus, results from studies of both TVCV
and early TMV intercellular movement suggest membranes as the
predominant vehicle controlling tobamovirus intercellular move-
ment. These ﬁndings also support those from a previous study
showing that both the viral replication proteins and MP are neces-
sary to allowmaximumdiffusion throughPDof GFP-fused probes
representing soluble ER membrane-bound proteins (Guenoune-
Gelbart et al., 2008). It was concluded that the results best support
a model in which the virus complex, perhaps consisting of viral
RNA,MP and other proteins, diffuses on the ER membrane within
the PD from infected to uninfected cells driven by a concentra-
tion gradient (Guenoune-Gelbart et al., 2008). The involvement
of the ER directly in virus movement, without prior transport
through Golgi, is supported by the ﬁnding that inhibition of the
COP II transport system through expression of a dominant nega-
tive GTPase mutant protein, Sar1, did not inhibit sustained TMV
intercellular movement (Genovés et al., 2010).
Irrespective of the mechanism of early movement between cells
by TMV, an explanation of this virus’s requirement for microﬁl-
aments for sustained movement is required. Harries et al. (2010)
suggested that the inﬂuence of microﬁlaments on this activity may
be in preventing a stress response from occurring at the PD that
later signaled to cells in advance of virus spread. These cells would
then modify their metabolism in preparation for the arrival of the
virus. Here we hypothesize that it is the transport of theVRC from
the cell wall/PD area to an internal subcellular location on the
actomyosin array that is necessary to prevent the stress signal from
moving to the next cell (Figure 1). On treatment with LatB or
silencing of myosin XI-2, the TMV VRCs would remain at the cell
wall/PD interface, inhibiting normal cell–cell communications.
This stress would be signaled to the cells in advance of the virus
spread and modify these cells to inhibit subsequent virus spread.
This hypothesis is supported by the ﬁnding that theVRCs of TMV
move away from the cell wall as the infection passes (Szécsi et al.,
1999). This interpretation would also accommodate the ﬁnding
that early TMV movement is unaffected by actomyosin inhibitors
since it would take some time to signal in advance of the infection
front to stop virus movement. In addition, it would explain the
lack of effect of LatB on TVCV movement since the 125 kDa pro-
tein, the homolog of the 126 kDa protein of TMV, does not form
intracellular inclusions that associate with microﬁlaments (Har-
ries et al., 2009) and the virus itself produces few visible VRCs
(Resconich, 1961). The transport of the TMV VRC or its rem-
nants from the wall may require membranes and vesicles since the
TMV MP binds with a plant synaptotagmin in vitro (Lewis and
Lazarowitz, 2010). Synaptogamins are a family of Ca2+- and lipid-
binding proteins that modulate, through interaction with SNARE
proteins, the fusion of vesicles with membranes (Chapman, 2008).
A dominant negative synaptotagmin mutant caused depletion
of endosomes and inhibited intercellular trafﬁcking of the MP-
GFP fusion (Lewis and Lazarowitz, 2010). The direct inﬂuence of
synaptotagmin on virus physiology appears to be on the endo-
cytic pathway, implying that the effect of the dominant negative
synaptotagmin on virus movement is through blocking the recy-
cling of membrane used by the virus to reach the cell wall/PD area,
thus backing up the system (Figure 1). This hypothesis, suggesting
a requirement for actomyosin-mediated vesicle trafﬁcking of the
VRC or VRC components from the wall membranes for sustained
virus movement, can be evaluated through cell biological studies.
Regarding non-cytoskeletal or membrane-associated proteins
and TMV intercellular movement, a gene encoding a class II
KNOTTED1-like protein, NTH201, was cloned from Nicotiana
tabacum and its expression levels were positively correlated with
MP accumulation, VRC numbers and virus spread (Yoshii et al.,
2008). NTH201 has no ability to trafﬁc between cells or trafﬁcGFP,
unlike class IKNOX-like plant proteins, and the authors speculated
that NTH201 may function as a transcription factor that helps to
stabilize or fold MP and VRCs through its regulation of other
genes. This mystery was partially explained when a second host
factor, MPIP1, a DnaJ-like protein with potential chaperone activ-
ity, was determined to interact with TMV MP and NTH201 in a
yeast-three hybrid screen (Shimizu et al., 2009). Silencing MPIP1
inhibits TMV spread, as determined by GFP ﬂuorescence, and
thus its silencing phenocopies observations of TMV spread when
NTH201 expression was silenced. It is possible that an interaction
between two host proteins and the TMV MP aid in transport of
virus between cells (Figure 1).
CONCLUSION
Cell biological studies over the last 20 years have tremendously
aided our understanding of TMV accumulation and spread. With-
out advanced molecular and biochemical technologies allowing
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virus and virus component labeling and advanced imaging hard-
ware our understanding of the individual processes during virus
spread would be diminished. For example, if virus intercellular
movement were studied by genetics alone the importance of the
transport of TMV vRNA granules to the perinuclear region of the
ER versus the transport of TMVVRCs and MPs to the PD could go
unrecognized. This said, some cell biological studies have yielded
conﬂicting or controversial results. This is especially true of phar-
macological studies and researchersmust carefully control asmany
variables in these studies as possible. In addition, conclusions from
pharmacological studies should be veriﬁed using other methods.
Use of novel virus labeling techniques and advanced microscopes
will allow further advances in this area. For example, the identiﬁca-
tion of small ﬂuorescent tags that do not inﬂuence the function of
the viral protein to which it is fused will be helpful. The iLOV pro-
tein, derived from the blue light receptor phototropin and much
smaller than GFP, has been available for some time and was a
ﬁrst step toward utilizing smaller ﬂuorescent tags (Chapman et al.,
2008). More recently a MYB-related transcription factor, Rosea 1,
which is also smaller thanGFP,has beenplaced inTMVas amarker
for virus location (Bedoya et al., 2012). Advanced microscopes
with super high resolution will allow us to more easily determine
whether proteins are interacting or simply co-localizing (Tilsner
and Oparka, 2010). Access to the N. benthamiana genome (Bom-
barely et al., 2012) will allow better identiﬁcation of gene family
members projected to inﬂuence virus transport and the ability
to target individual members for knockdown, over-expression
and labeling. Lastly, recent ﬁndings suggest that while transport
of TMV to the PD is important, it is also important to under-
stand what happens to the virus inclusions left in the cell after
virus movement, since their proper degradation or storage may
inﬂuence sustained intercellular movement by the virus. As an
analogy, although humans can function well for a time in their
home (i.e., cell) without working plumbing, a plugged drain,
like a plugged PD, will eventually be noticed. With our improv-
ing technologies, resources, and knowledge the future is bright,
literally, for cell biological studies on TMV accumulation and
spread.
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